They found 20% of small bowel adenocarcinomas showed SATB2 expression; however, the positive ratio was lower in CD-associated adenocarcinomas (12%) than in sporadic or celiac disease-associated adenocarcinomas, suggesting CD-associated small bowel adenocarcinomas are less likely to have large bowel differentiation. This evidence concerns the gene SATB2 and celiac disease.